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Abstract
Fe deﬁciency is relatively common in pregnancy and has both short- and long-term consequences. However, little is known about the effect
on the metabolism of other micronutrients. A total of ﬁfty-four female rats were fed control (50mg Fe/kg) or Fe-deﬁcient diets (7·5mg/kg)
before and during pregnancy. Maternal liver, placenta and fetal liver were collected at day 21 of pregnancy for Cu and Zn analysis and to
measure expression of the major genes of Cu and Zn metabolism. Cu levels increased in the maternal liver (P= 0·002) and placenta (P= 0·018)
of Fe-deﬁcient rats. Zn increased (P< 0·0001) and Cu decreased (P= 0·006) in the fetal liver. Hepatic expression of the Cu chaperones
antioxidant 1 Cu chaperone (P= 0·042) and cytochrome c oxidase Cu chaperone (COX17, P= 0·020) decreased in the Fe-deﬁcient dams,
while the expression of the genes of Zn metabolism was unaltered. In the placenta, Fe deﬁciency reduced the expression of the chaperone for
superoxide dismutase 1, Cu chaperone for superoxide dismutase (P= 0·030), ceruloplasmin (P= 0·042) and Zn transport genes, ZRT/IRT-like
protein 4 (ZIP4, P= 0·047) and Zn transporter 1 (ZnT1, P= 0·012). In fetal liver, Fe deﬁciency increased COX17 (P= 0·020), ZRT/IRT-like
protein 14 (P= 0·036) and ZnT1 (P= 0·0003) and decreased ZIP4 (P= 0·004). The results demonstrate that Fe deﬁciency during pregnancy
has opposite effects on Cu and Zn levels in the fetal liver. This may, in turn, alter metabolism of these nutrients, with consequences for
development in the fetus and the neonate.
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Fe deﬁciency is the most common nutrient deﬁciency world-
wide and is particularly prevalent in children, women of child
bearing age and pregnant women. Even in the UK, it is esti-
mated that 23% of women aged 19–64 years and nearly half of
teenage girls do not reach their lower reference nutrient intake
for Fe(1). During development, the fetus relies entirely on
maternal supply for Fe, Zn and Cu, which are critical for
development and health. Crosstalks between these three trace
elements have been established decades ago(2–4), but the effect
of Fe deﬁciency on the metabolism of Cu and Zn is still not fully
understood, particularly during pregnancy. The ability to carry
out work establishing these links is, of course, limited, but
micronutrient metabolism is well-conserved in mammals, and
the rat has been shown to be a very good model for pregnancy
and nutrition in humans(3).
Generally, Fe deﬁciency in mammals results in increased Cu
levels in the blood, gut and liver(5–7). Circulating ceruloplasmin
(CP), produced by the liver, and its gut homologue hephaestin
are Cu-dependent ferroxidases and appear as an evident link
between Fe and Cu metabolism. Accordingly, Fe deﬁciency
in rats induces an increase in serum Cu associated with an
increase in CP levels(5). Interestingly, Fe-deﬁcient rats have
higher liver Cu levels that correlate with CP expression and
its ferroxidase activity, while hepatic CP mRNA remains
unchanged, suggesting that Cu loading is associated with an
increased metallation of the protein(8). Fe deﬁciency also
increases the expression of the Menkes Cu ATPase (ATP7a) in
the duodenum(6,9), suggesting an increased export of Cu from
the enterocyte to the circulation, while Wilson Cu ATPase
(ATP7b) expression in the liver is unaltered(6). In addition, Cu
and Fe may compete for divalent metal transporter 1 (DMT1)
for their uptake in the gut. Although Cu inﬂux through DMT1
in the enterocyte is minor compared with Cu transporter 1
(CTR1) in replete conditions, it is of particular importance
during Fe deﬁciency due to its up-regulation and the lack of
Fe in the lumen, which favours Cu uptake(10).
Abbreviations: ATOX1, antioxidant 1 copper chaperone; CCS, copper chaperone for superoxide dismutase; COX17, cytochrome c oxidase copper chaperone;
CP, ceruloplasmin; ZIP, ZRT/IRT-like protein; ZnT, zinc transporter.
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The effect of Fe deﬁciency on Zn status is believed to be less
important than on Cu status. Fe deﬁciency appears to reduce Zn
requirements in rats, increasing Zn levels in several organs such
as liver, spleen, brain or kidney(11,12) while decreasing apparent
Zn absorption(13) and plasma Zn(14). Noteworthy, marginal Fe
deﬁciency (9 and 13mg Fe/kg diet) did not affect Zn status in
rat, while it was sufﬁcient to induce Cu accumulation in the
liver(15). Because Fe and Zn have similar mechanisms of
absorption and transport in the gut, they were originally thought
to compete with each other, notably through DMT1. Accord-
ingly, Fe treatment reduces the transport of Zn in Caco-2 cells
although to a lesser extent than other divalent cations(16).
However, DMT1’s afﬁnity for Zn is much lower than that for Fe,
and its contribution to Zn transport and uptake is probably
minimal(17).
Two families of Zn transporters (ZnT) have been identiﬁed,
ZRT/IRT-like protein (ZIP) and ZnT, generally involved in
inﬂux and efﬂux of the cells, respectively. ZIP stands for Zn-
regulated transporter, Fe-regulated transporter-like protein, and
is composed of 14 members in mammals. They are char-
acterised by their ability to transport Zn, but several of them
have also been reported to mediate the uptake of Fe as well as
Mn(18). In rats, Fe overload increases the expression of several
ZIP in the liver, namely, ZIP5 (up), ZIP6, ZIP7 and ZIP10
(down), while ZIP14, the most abundant ZIP in the liver, is
upregulated by Fe deﬁciency(19). On the other hand, the ZnT
family comprises 10 members so far and contribute to Zn
homoeostasis by exporting Zn out of the cell or sequestrating
Zn into cellular compartments when Zn levels are low. While
there is evidence for direct action of Fe on ZIP, which may lead
to alterations in Zn metabolism, interactions between Fe and
ZnT have not been identiﬁed.
Metabolic crossroads between Fe, Cu and Zn during preg-
nancy are less known. Maternal Fe deﬁciency in rat increases
Cu levels in the maternal liver, maternal serum as well as the
placenta(20,21) along with an increase in serum Cu and CP(22). In
contrast, we showed that Fe deﬁciency decreased Cu levels in
the fetal liver, without affecting the fetal expression of the main
genes involved in Cu metabolism(23,24). In humans, Fe supple-
mentation has been shown to decrease plasma Zn levels during
pregnancy and Zn absorption during lactation in humans(25–27).
Whether Fe deﬁciency, as opposed to overload, affects Zn
metabolism in the mother and fetus remains essentially
unknown. In this study, we investigated the effect of maternal
Fe deﬁciency on Zn status in pregnant rats and the offspring as
well as the implication of major genes of Zn metabolism. We
also examined the mechanisms through which Fe deﬁciency
differentially affects Cu metabolism in the mother and fetus and
tested the implication of most genes of Cu metabolism in the
liver of the mother and fetus as well as in the placenta.
Methods
Animal procedures
Experiments were performed using female Rowett hooded rats
from three different studies of identical design. The protocol
and animal procedures have recently been described in
detail(28) and were approved by the Rowett Institute Ethics
Committees and conducted in accordance with the UK Animals
(Scientiﬁc Procedures) Act 1986. Brieﬂy, 54 weanling females
were fed a control diet (AIN93, containing 860mg/kg Zn and
170mg/kg Cu) for two weeks and were then randomised
into two groups. In all, 30 remained on the control diet
(Fe= 50mg/kg) for four weeks until mating and 24 switched to
an Fe-deﬁcient (Fe= 7·5mg/kg) diet for the same duration.
They were mated with males of the same strain and remained
on the same diet until they were killed at day 21 of gestation.
Dams were killed by stunning and cervical dislocation and the
fetuses by decapitation. Animals were housed under 12-h light–
12-h dark cycle with a constant temperature (22°C). No adverse
effects were recorded as a result of this dietary intervention.
Livers from the dams and fetuses, as well as the placentas,
were collected and immediately frozen in liquid N2. They were
kept in metal-free vials and stored at –80°C until analysis.
Whenever possible, placentas and fetal livers from the three
male median weights in each litter were pooled together and
ground in liquid N2. Ground tissues from maternal liver, pooled
placentas and pooled fetal livers were used for Fe, Cu and Zn
content (control n 24, Fe deﬁcient n 30) and gene analysis
(control n 21, Fe deﬁcient n 24). It should be noted that control
and Fe-deﬁcient samples from each of the three animal studies
were analysed together, and results from each experiment were
then pooled together for data analysis.
Assessment of copper and zinc status
Total Cu and Zn were measured in maternal liver, placenta and
fetal liver by inductively coupled plasma (ICP)-MS as described
previously(28). Samples were digested in 2% HNO3, 0·5% HCl
and metal concentrations measured using an Agilent 7700X
spectrophotometer (Agilent Technologies) equipped with a
MicroMist nebuliser, Ni sampler and skimmer cones. Intra-assay
CV% were 10·8% (Fe), 11·1% (Cu) and 5·2% (Zn).
RNA extraction and real-time RT-quantitative PCR
In all, 20–30mg of frozen placenta, maternal and fetal liver
ground tissue were homogenised after grinding, using a T25
Ultra-Turrax (IKA (England) Ltd). RNA was isolated with the
RNeasy Mini Kit (Qiagen), and 200 ng was reverse transcribed
on a PTC-100 Thermal Cycler (Bio-Rad Laboratories) using the
Applied Biosystems TaqMan RT reagent kit (Life Technologies).
Complementary DNA fragments were ampliﬁed by real-time
quantitative PCR (7700 Sequence Detection System; Life Tech-
nologies) using the primers (TaqMan; ThermoFisher Scientiﬁc)
described in Table 1. The most relevant genes of Cu(24) and Zn
metabolism were selected. Speciﬁcally, ZIP-1 is ubiquitously
expressed and was shown to bind Fe with high afﬁnity(29).
ZIP-4 is crucial during development and for the absorption of
maternal Zn(30). ZIP8 and ZIP14 are closely related and have
been shown to mediate Fe transport in addition to Zn(31,32).
ZnT1 (ubiquitous), ZnT4 and ZnT5 are sensitive to maternal Zn
status and may play an important role in fetal Zn supply from
the maternal diet(33,34). The gene expression was normalised to
18s rRNA (HS99999901_s1) in all samples. This was chosen
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although the levels of expression were higher than the test
genes because it was the only gene that was consistently
unaffected by the nutritional treatments (G Roussel and HJ
McArdle, unpublished results).
The experiment was performed and data interpreted
according to the Minimum Information for Publication of
Quantitative Real-Time PCR Experiments guidelines(35): 18s
RNA expression did not signiﬁcantly vary between the Fe-
deﬁcient and control groups in all tissues (Mann–Whitney test,
data not shown). Linear ampliﬁcation was observed for 18s and
all genes of interest across their range of expression.
Statistical analysis
Fe, Cu and Zn content are expressed in µg/g dry tissue. The
material used in this article were obtained from three separate
experiments. To minimise variations between the three animal
studies, as well as between each PCR run, the expression of Cu
and Zn genes was expressed as percentage of the average gene
expression of the control group for each of the three experi-
ments. The normality of the distribution and equality of var-
iances were analysed with GraphPad Prism (version 5.04). Data
were analysed with IBM SPSS statistics 21.0 software using
unpaired t tests when data were normally distributed and
otherwise using non-parametric tests (Mann–Whitney U).
Results
Copper and zinc levels
The effect of maternal Fe deﬁciency on growth, placental:fetal
ratio, placenta and liver weights, haematocrit and Fe levels
in this study has been recently reported(28). Speciﬁcally, Fe
levels were decreased by 152·6 µg/g (approximately –30%),
604·0 µg/g (approximately –60%) and 369·4 µg/g dry tissue
(approximately –75%), in the placenta, fetal and maternal liver,
respectively(28). Maternal liver and placenta weight were not
affected by Fe deﬁciency, while fetal weight and fetal liver
weight were signiﬁcantly decreased by approximately 13% and
25%, respectively(28). Maternal Fe deﬁciency increased Cu
levels by 1·44 µg/g dry tissue (95% CI 0·34, 2·54; P= 0·002) and
3·45 µg/g (95% CI –0·42, 7·32; P= 0·018) in maternal liver and
placenta, respectively. In contrast, Fe deﬁciency decreased Cu
levels in the fetal liver by 9·64 µg/g (95% CI –15·85, –3·42;
P= 0·006) (Fig. 1(a), Mann–Whitney), while Zn levels were
increased by 81·6 µg/g (95% CI 50·0, 113·1; P< 0·0001). Zn
levels in maternal liver and placenta were not signiﬁcantly
altered by maternal Fe deﬁciency (Fig. 1(b), t test). Changes in
absolute levels of Fe, Zn and Cu followed a similar pattern
(Table 2) apart from the absolute Zn levels that were reduced
by 4·08 µg (95% CI –1·64, –6·52; P= 0·003) in the fetal liver.
Zinc and copper gene expression
Maternal Fe deﬁciency decreased the hepatic expression of
the Cu chaperones antioxidant 1 Cu chaperone (ATOX1) by
–10·5% (95% CI –20·7, –0·4; P= 0·042) and cytochrome c oxi-
dase Cu chaperone (COX17) by –13·8% (95% CI –25·3, –2·3;
P= 0·020) in the dams. In contrast, the hepatic expression of
COX17 was increased by 15·0% (95% CI 2·5, 27·5; P= 0·020) in
Table 1. List of genes analysed by PCR using TaqMan® Gene Expres-
sion Assays (ThermoFisher Scientific)
Gene Protein Assay ID
ATOX1 Antioxidant 1 Cu chaperone Rn00584459_m1
COX17 Cytochrome c oxidase
Cu chaperone
Rn00585530_m1
CCS Cu chaperone for
superoxide dismutase
Rn00584772_m1
CP Ceruloplasmin Rn00561049_m1
ATP7A ATPase Cu transporting
alpha (Menkes)
Rn00583815_m1
ATP7B ATPase Cu transporting
beta (Wilson)
Rn00560862_m1
SLC31A1/CTR1 Cu transporter 1 Rn00683634_m1
SLC39A1/ZIP1 ZRT/IRT-like protein 1 Rn01458936_g1
SLC39A4/ZIP4 ZRT/IRT-like protein 4 Rn01505595_g1
SLC39A8/ZIP8 ZRT/IRT-like protein 8 Rn01748352_m1
SLC39A14/ZIP14 ZRT/IRT-like protein 14 Rn01468336_m1
SLC30A1/ZnT1 Zn Transporter 1 Rn00575737_m1
SLC30A4/ZnT4 Zn Transporter 4 Rn00597094_m1
SLC30A5/ZnT5 Zn Transporter 5 Rn01493867_m1
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Fig. 1. Effect of maternal iron deficiency on copper (a) and zinc (b) levels in
maternal liver, placenta and fetal liver 21 d after mating (n 54). Values are mean
percentage of control, with their standard errors represented by vertical bars.
Results are significantly different between the control (Ctrl, n 24) and
iron-deficient (Fe Def, n 30) groups: **** P< 0·0001 (independent t test);
† P< 0·05, †† P< 0·01 (Mann–Whitney test).
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the fetus. In the placenta, Fe deﬁciency led to a decrease in Cu
chaperone for superoxide dismutase (CCS), the chaperone that
delivers Cu to superoxide dismutase (SOD)1, by –9·5% (95% CI
–18·0, –1·0; P= 0·030) and CP by –15·0% (95% CI –29·4, –0·5;
P= 0·042) expression (Fig. 2).
The maternal hepatic expression of the genes related to Zn
metabolism was not affected by Fe deﬁciency. In the placenta,
ZIP4 was reduced by –23·7% (95% CI –47·0, –0·4; P= 0·047)
and ZnT1 by –12·3% (95% CI 21·8, –2·8; P= 0·012) in the Fe-
deﬁcient group compared with control (Fig. 3). In fetal liver, Fe
deﬁciency also decreased ZIP4 by –17·0% (95% CI –28·1, –5·8;
P= 0·004), while ZIP14 and ZnT1 were increased by 10·0%
(95% CI 0·7, 19·3; P= 0·036) and by 18·7% (95% CI 9·0, 28·4;
P= 0·0003), respectively (Fig. 3).
The effect of maternal Fe deﬁciency on Cu and Zn metabo-
lism observed in the current study is summarised in Table 3.
Discussion
In this article, we examined the interactions between Fe, Cu and
Zn during pregnancy in the rat. The study has some limitations
in that the data can only be extrapolated to humans to a limited
extent. However, given how well-conserved micronutrient
metabolism is between species, it is likely that the same results
would be observed in humans with Fe deﬁciency. We restricted
our measurements to liver and placenta, as these are the major
organs involved in micronutrient metabolism(3). Fe deﬁciency
altered Cu but not Zn concentrations in the maternal liver and
placenta, conﬁrming that the metabolism of Cu is more sensitive
to Fe deﬁciency than that of Zn(15). However, maternal Fe
deﬁciency had an important impact on both Cu and Zn levels in
the fetal liver, which were reduced by approximately 15% and
augmented by approximately 25%, respectively.
Effect of maternal iron deﬁciency on copper metabolism
Maternal Fe deﬁciency leads to the hepatic accumulation of Cu
in the dams, while Cu levels are decreased in the fetal liver, as
described previously by our group, as well as others(20,21,23).
Interestingly, Fe deﬁciency decreased the expression of the
chaperones ATOX1 and COX17 in the maternal liver, con-
trasting with our previous ﬁndings, where no change in ATOX1
mRNA levels was observed(23). It is important to note that in our
previous experiment, COX17 was not measured and ATOX1
was only measured in six samples. Further, the previous study
used Northern blotting to detect expression levels which is less
sensitive than using RT-PCR. The present study included 45
samples, which allows us to detect smaller changes with greater
sensitivity.
ATOX1 does not seem to be involved in Cu uptake but is a Cu
chaperone that interacts with ATP7A and ATP7B and delivers Cu
to these pumps and hence to trans-Golgi network(36) or possibly
the efﬂux pathway of the placenta(37). Moreover, ATOX1
appears essential to peri-natal Cu homoeostasis(38) for synthesis
of CP or export from the cell into the portal circulation (ATP7A in
gut) or into the bile for excretion (ATP7B). Understandably, the
inhibition of ATOX1 expression reduces the trafﬁcking of
ATPases(39), thus reducing Cu export and causing its accumu-
lation in the cell(40). Therefore, the small but signiﬁcant reduc-
tion in ATOX1 expression in the Fe-deﬁcient liver could be
responsible – at least partially – for the increase in Cu levels.
In addition, the hepatic expression of COX17, a chaperone
delivering Cu to the cytochrome oxidase complex in the
respiratory chain, was also decreased. The impairment of
mitochondrial function and the reduction in cytochrome c
activity (which requires both Fe and Cu to function) is well-
established in Fe-deﬁcient tissues, including in the liver(41,42),
Table 2. Organ weight, water content and absolute iron, copper and zinc content in the maternal liver, placenta and fetal liver
of control and iron-deficient rats at day 21 of gestation
(Mean values with their standard errors)
Control Fe deficient
Mean SEM Mean SEM
Maternal liver
Organ weight (g)‡ 10·94 0·39 11·60 0·35
Water content (%)§ 70·04 0·26 71·22** 0·24
Absolute Fe content (mg)‡ 1·96 0·29 0·70†† 0·12
Absolute Cu content (µg)‡ 44·77 1·20 51·10* 1·48
Absolute Zn content (µg)‡ 305·9 8·2 326·8 8·5
Placenta
Organ weight (g)|| 0·512 0·017 0·551 0·009
Water content (%)§ 87·83 0·24 88·10 0·27
Absolute Fe content (mg)|| 39·07 1·88 28·47*** 1·66
Absolute Cu content (µg)|| 1·17 0·10 1·52 0·09
Absolute Zn content (µg)|| 5·52 0·20 5·60 0·19
Fetal liver
Organ weight (g)‡ 0·313 0·009 0·234*** 0·009
Water content (%)§ 78·23 0·21 79·26* 0·18
Absolute Fe content (mg)‡ 80·37 2·38 20·08††† 1·14
Absolute Cu content (µg)‡ 3·62 0·27 1·90*** 0·15
Absolute Zn content (µg)‡ 23·37 0·87 19·27** 0·85
Mean values were significantly different compared with control: * P<0·05, ** P<0·01, *** P<0·001 (independent t test).
Mean values were significantly different compared with control: †† P<0·01, ††† P<0·001 (Mann–Whitney U test).
‡ n 16 (eight control, eight Fe deficient).
§ n 54 (twenty-four control, thirty Fe deficient).
|| n 38.
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Fig. 2. Effect of maternal iron deficiency on the expression of genes related to copper metabolism (n 45) 21 d after mating: (a) maternal liver; (b) placenta; (c) fetal liver.
Values are mean percentage of control, with their standard errors represented by vertical bars. * Results are significantly different between the control (Ctrl, n 21) and
iron-deficient (Fe Def, n 24) groups (P< 0·05; Mann–Whitney test). ATOX1, antioxidant 1 copper chaperone; COX17, cytochrome c oxidase chaperone; ATP7A,
ATPase copper transporting alpha (Menkes); ATP7B, ATPase copper transporting beta (Wilson); CCS, copper chaperone for superoxide dismutase; CP,
ceruloplasmin; CTR1, copper transporter 1.
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Fig. 3. Effect of maternal iron deficiency on the expression of genes related to zinc metabolism (n 45) 21 d after mating: (a) maternal liver; (b) placenta; (c) fetal liver.
Values are mean percentage of control, with their standard errors represented by vertical bars. Results are significantly different between the control (Ctrl, n 21) and
iron-deficient (Fe Def, n 24) groups: * P< 0·05, ** P< 0·01, *** P< 0·001 (Mann–Whitney test). ZIP1, ZRT/IRT-like protein 1; ZIP4, ZRT/IRT-like protein 4; ZIP8, ZRT/
IRT-like protein; ZIP14, ZRT/IRT-like protein 14; ZnT1, zinc transporter 1; ZnT4, zinc transporter 4; ZnT5, zinc transporter 5.
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although whether this is cause or consequence is not certain at
this time. There are little data on the direct effects of Cu on
either ATOX1 or COX17 expression, so the possibility that these
changes are a response to changes in Cu levels, rather than Cu
levels being changed by the alterations in gene expression,
cannot be excluded in these experiments.
As observed previously(23), maternal Fe deﬁciency led to the
increase in Cu levels in the placenta (approximately 19%) to a
greater extent than the maternal liver (approximately 10%).
This was accompanied by the reduction in CCS expression,
another chaperone channeling Cu for incorporation into the
Cu–Zn superoxide dismutase (SOD) complex, an essential
component of the anti-oxidant cell system. Cu has been shown
to modulate the degradation of CCS(43) and Cu supplementation
in humans reduces CCS mRNA levels in peripheral mono-
nuclear cells(44). It is likely that the down-regulation of CCS
expression observed here is due to the presence of elevated Cu
levels in the placenta, rather than a direct consequence of
reduced Fe levels. Our ﬁndings suggest that maternal Fe deﬁ-
ciency leads to the impairment of SOD activity (closely related
to CCS expression) and the anti-oxidant defense of the placenta
as observed in liver and brain cells upon Cu accumulation(45,46).
CP is involved in Fe export in the liver, oxidising Fe(II) to
Fe(III) for incorporation into transferrin, while its homologue
zyklopen performs the same function in placenta in mice and
humans(47). Whether the ferroxidase mRNA measured in the
placenta is zyklopen, CP or a combination of both remains
uncertain, since the sequences are very similar and because the
primers are from a commercial supplier. However, it is likely
that we measured the mRNA coding for a multi-copper oxidase
responsible for Fe export(48). The effect that the reduced pla-
cental expression might have on Fe transport is not clear and
contrasts with previous ﬁndings(48). However, it is important to
note that CP protein and enzyme levels do not correlate with
mRNA levels(49) and that changes in CP mRNA expression
observed in the present study may therefore have little phy-
siological impact. Maternal Fe deﬁciency is partly alleviated in
the fetus, due to increased expression of transferrin recep-
tors(50,51), which would imply that ferroxidase expression or
activity is not rate limiting.
Cu transport across the placenta is less well-understood. Cu
appears to be taken up from the maternal circulation through
CTR1 and excreted through ATPases(52,53). It has been suggested
that ATP7A is responsible for the efﬂux of Cu from the basolateral
membrane into the fetal circulation, while ATP7B is responsible
for excreting Cu back into the maternal circulation at the apical
side(54). Whether CP and/or zyklopen are involved in Cu efﬂux
and/or delivery to the fetal liver, as we have previously(54) sug-
gested for transport of Cu from the mother to the placenta(55),
and whether this could explain the differences observed in Cu
levels between placenta and fetal liver remain to be clariﬁed.
Effects of maternal iron deﬁciency on zinc metabolism
The effect of Fe deﬁciency on Zn metabolism in the pregnant
rat is less marked than for Cu but is nonetheless signiﬁcant. Zn
levels in the maternal liver and placenta were not changed but
were markedly increased in the fetal liver.
In the maternal liver, the expression of the genes of Zn
metabolism tested were unchanged, which is consistent with
the lack of effect on Zn levels but contrasts with previous
ﬁndings in male rats, where Fe deﬁciency led to an increase in
hepatic ZIP14 expression(19). It should be noted, however, that
the authors also observed a small decrease in Zn levels which
was not seen in the present study nor in their other study of a
similar design(19). Taken together, these results imply that Fe
deﬁciency during pregnancy is unlikely to lead to changes in
Zn metabolism that are physiologically important in the
maternal liver.
While Zn levels were unchanged in the placenta, ZIP4 and
ZnT4, genes of Zn cellular uptake and exit, respectively, were
both decreased in the placenta. The results do not fully match
those seen in mice given a Zn-deﬁcient diet, where ZnT4 and
also ZIP1, ZnT1 and 5 were reduced in placenta(33). It is pos-
sible that there was a mild reduction in Zn supply to and in
efﬂux from the placenta, with a neutral net effect on Zn levels in
the placenta. Zn metabolism and transport in the placenta are
still not entirely understood, and the role and localisation of
ZIP4 in the placenta are not known. ZIP4 is crucial for Zn
cellular uptake in the small intestine and is up-regulated upon
Zn deﬁciency in mice(56). It is also abundantly expressed in
other tissues involved in nutrient absorption and reabsorption
(stomach, colon and kidney)(57). While ZIP4 expression could
not be compared with intestinal or kidney expression in the
present study, it is important to note that it was higher in the
placenta compared with maternal liver (approximately 2-fold)
and fetal liver (approximately 15-fold, data not shown). This
suggests that the changes observed in placental expression
could be biologically relevant, and further research is warranted
to clarify the role of ZIP4 in placenta. If it was involved in the
Table 3. Summary of the effect of maternal iron deficiency on copper and
zinc metabolism in maternal liver, placenta and fetal liver at day 21 of
pregnancy*
Gene Maternal liver Placenta Fetal liver
Cu† ↑↑ ↑ ↓
ATOX1‡ ↓ = =
COX17‡ ↓ = ↑
CCS‡ = ↓ =
CP‡ = ↓ =
ATP7A‡ = = =
ATP7B‡ = = =
CTR1‡ = = =
Zn† = = ↑↑
ZIP1‡ = = =
ZIP4‡ = ↓ ↓
ZIP8‡ = = =
ZIP14‡ = = ↑
ZnT1‡ = = ↑
ZnT4‡ = ↓ =
ZnT5‡ = = =
ATOX1, antioxidant 1 Cu chaperone; COX17, cytochrome c oxidase Cu chaperone;
CCS, Cu chaperone for superoxide dismutase; CP, ceruloplasmin; ATP7A, ATPase
Cu transporting alpha (Menkes); ATP7B, ATPase Cu transporting beta (Wilson);
CTR1, Cu transporter 1; ZIP, ZRT/IRT-like protein; ZnT, Zn transporter.
* The concentrations of Cu, Zn, and the expression of genes of Cu and Zn metabolism
were either greatly increased (↑↑), increased (↑), decreased (↓) or unchanged (= )
by maternal Fe deficiency.
† n 54 (control n 24, Fe deficient n 30).
‡ n 45 (control n 21, Fe deficient n 24).
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return of Zn from fetal to maternal circulation, then decreased
expression could result in increased levels of Zn in the fetal
liver. Interestingly, neither ZIP8 nor ZIP14, both of which have
previously been implicated in Fe metabolism as well as that of
Zn(32), are altered in the placenta or maternal liver, which would
argue against the changes in fetal liver Zn levels being a direct
consequence of competition with Fe for these transporters.
Fe deﬁciency leads to an increase in Zn levels in the fetal liver
but also a lesser decrease in Fe levels compared with the
decrease observed in the maternal liver(58). Both these changes
may be explained, at least partially, by an upregulation of
ZIP14, which mediates the uptake of Zn, as well as non-
transferrin-bound Fe(31), and thus could help protect the fetus
against Fe deﬁciency. It is important to note that this does not
rule out other mechanisms, such as an increased expression of
transferrin receptors, as we have previously observed in the
placenta of rats and women(50,51). On the other hand, the
reduced ZIP4 expression in the fetal liver is more likely to be a
consequence of the increase in Zn levels as has been seen in Zn
overload observed in the intestine and visceral yolk sac of
mice(56). In addition, as described earlier in this discussion, ZIP4
expression in the fetal liver was fairly low compared with the
other tissues, indicating that its changes may have little biolo-
gical relevance.
Contrasting with our results, ZnT1 hepatic upregulation has
been reported in Zn-deﬁcient rats in association with Zn
depletion in the liver(59), although this was only observed at the
protein level. Whether the increase in ZnT1 mRNA expression
in the fetal liver would lead to an increase in protein levels is
uncertain, and whether this could lead to more Zn efﬂux back
into the fetal circulation is unlikely in the present study. The
reasons why ZnT1 upregulation is associated with a marked
increase in Zn levels are not known, and the role of ZnT1 in
fetal liver Zn metabolism needs to be clariﬁed.
In summary, this study has shown that Fe deﬁciency has
opposite effects on Cu and Zn levels in the fetal liver, and this is
associated with changes in the expression of genes of Cu and Zn
metabolism in the placenta as well as in the fetus. It is important
to note that some of these effects may not be directly caused by
Fe deﬁciency but rather by changes in the metabolism of the
other two nutrients. The results further demonstrate that micro-
nutrient metabolism, especially during pregnancy, is tightly
interlinked and underscores the importance of considering all of
the micronutrients when trying to alleviate deﬁciencies in one of
them. It would be important to consider that the symptoms
caused by deﬁciencies in onemicronutrient (here Fe) may not be
caused directly by that deﬁciency but by other deﬁciencies or
overloads occurring as a consequence of the primary defect.
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